Th17 cells, specifically implicated in autoimmune diseases including type 1 diabetes, can secrete IL-22 and IL-17A, which has been identified as a factor promoting the pro-inflammatory effect of IL-22 [45–48]. This evidence concerns the gene IL17A and type 1 diabetes mellitus.